Pilot study on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion.

Trial Profile

Pilot study on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Ocriplasmin (Primary)
  • Indications Central retinal vein occlusion
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Sep 2017 Status changed from recruiting to completed.
    • 14 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top